Education
About Us
Working with TipRanks
Follow Us
ExpreS2ion Biotech Holding AB (SE:EXPRS2)
:EXPRS2
RESEARCH TOOLSreports
EXPRS2 Stock Chart & Stats
Day’s Range― - ―
52-Week Rangekr15.74 - kr66.52
Previous CloseN/A
Volume135.00
Average Volume (3M)27.62K
Market Cap
€60.48M
Enterprise Value-kr30.14M
Total Cash (Recent Filing)€81.54M
Total Debt (Recent Filing)kr360.00K
Price to Earnings (P/E)―
Beta0.30
Next Earnings
Aug 21, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.30
Shares Outstanding2,658,346
10 Day Avg. Volume42,166
30 Day Avg. Volume27,624
Financial Highlights & Ratios
PEG Ratio-0.08
Price to Book (P/B)0.66
Price to Sales (P/S)0.00
P/FCF Ratio-1.47
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EXPRS2 FAQ
What was ExpreS2ion Biotech Holding AB’s price range in the past 12 months?
ExpreS2ion Biotech Holding AB lowest stock price was kr15.74 and its highest was kr66.52 in the past 12 months.
What is ExpreS2ion Biotech Holding AB’s market cap?
ExpreS2ion Biotech Holding AB’s market cap is €60.48M.
When is ExpreS2ion Biotech Holding AB’s upcoming earnings report date?
ExpreS2ion Biotech Holding AB’s upcoming earnings report date is Aug 21, 2025 which is in 73 days.
How were ExpreS2ion Biotech Holding AB’s earnings last quarter?
ExpreS2ion Biotech Holding AB released its earnings results on May 15, 2025. The company reported -kr4.303 earnings per share for the quarter, missing the consensus estimate of N/A by -kr4.303.
Is ExpreS2ion Biotech Holding AB overvalued?
According to Wall Street analysts ExpreS2ion Biotech Holding AB’s price is currently Overvalued.
Does ExpreS2ion Biotech Holding AB pay dividends?
ExpreS2ion Biotech Holding AB does not currently pay dividends.
What is ExpreS2ion Biotech Holding AB’s EPS estimate?
ExpreS2ion Biotech Holding AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ExpreS2ion Biotech Holding AB have?
ExpreS2ion Biotech Holding AB has 2,658,346 shares outstanding.
What happened to ExpreS2ion Biotech Holding AB’s price movement after its last earnings report?
ExpreS2ion Biotech Holding AB reported an EPS of -kr4.303 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.132%.
Which hedge fund is a major shareholder of ExpreS2ion Biotech Holding AB?
Currently, no hedge funds are holding shares in SE:EXPRS2
Company Description
ExpreS2ion Biotech Holding AB
ExpreS2ion Biotech Holding AB (publ), through its subsidiary, ExpreS2 ion Biotechnologies ApS, develops and produces complex proteins for vaccines and diagnostics in Denmark. The company develops capsid virus-like particle COVID-19 vaccine, which is in Phase II clinical trial. It also develops influenza and breast cancer vaccine, which is in Phase II clinical trial, as well as develops malaria vaccine. In addition, the company licenses its ExpreS2 platform to research institutes and pharmaceutical companies. ExpreS2ion Biotech Holding AB (publ) was founded in 2015 is based in Horsholm, Denmark.
Technical Analysis
OncoZenge AB
―
Modus Therapeutics Holding AB
―
Spago Nanomedical AB
―
CombiGene AB
―
Sprint Bioscience AB
―